August 16, 2021

Vaxine’s COVID-19 vaccine technology has progressed to the final stages of a human clinical trial, after strong preliminary results demonstrating its ability to prevent coronavirus infections in animal models.
This highly effective protein-based vaccine can be manufactured on a large scale and remain stable in normal refrigerated conditions.
Read this full article here: Australian-made coronavirus vaccine COVAX-19 shows promise in trials
- Click to share on Facebook (Opens in new window)
- Click to share on Twitter (Opens in new window)
- Click to share on Telegram (Opens in new window)
- Click to share on LinkedIn (Opens in new window)
- Click to share on Reddit (Opens in new window)
- Click to share on WhatsApp (Opens in new window)
- Click to share on Tumblr (Opens in new window)
- Click to share on Pinterest (Opens in new window)
- Click to share on Pocket (Opens in new window)
- Click to email a link to a friend (Opens in new window)
- Click to print (Opens in new window)